Jubilant sees stronger EBITDA growth in 2009-10
This article was originally published in Scrip
Executive Summary
Jubilant Organosys, India's largest custom research and manufacturing services (CRAMS) company, expects to post stronger earnings growth for the year ending March 31st, 2010, supported by new contracts for manufacturing and R&D services.